You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Italy

Jul 2012

Price: US$2,400

About this Report

EXECUTIVE SUMMARY

Consumer Health experienced healthy growth in 2011

In 2011 consumer health fared well, reflecting the position that these products hold for Italian consumers. Italians are a mature population and spending on personal healthcare is considered an investment aimed to improve the quality of life and avoid illness. Consumers are increasingly well-educated about the efficacy of different brands and products, and buy accordingly.

Task-specific and new products led growth

The latter half of the review period has seen Italian consumers change their spending allocation within consumer health. There has been a switch towards very task specific products with products such as multivitamins and vitamin C losing ground to probiotics, fibre and mineral supplements. Consumers were also quick to try new products, with categories such as proton pump inhibitors, NRT lozenges and OTC obesity all posting high growth rates.

Consumer health is increasingly fragmented

The competitive environment remained rather fragmented in 2011, with a large number of companies operating in consumer health in Italy. Multinational companies continued to dominate, with Bayer remaining in the leading position, together with Aziende Chimiche Riunite Angelini Francesco ACRAF. Whitehall Italia ranked third, due to its strength in vitamins and dietary supplements. The leading players benefited from the growing preference for self-medication, with consumers tending to opt for well-known brands from trusted manufacturers.

Health and Beauty Retailers keep the lion’s share

Specialist retailers still represents the most important channel in consumer health. Retailers, manufacturers and the government were expecting a change within the distribution network after the liberalisation of the sale of over-the-counter (OTC) products. However despite the deregulation there has been little evidence of an increase in sales through grocery channels. Italian consumers still value the professional advice available in health specialists above the convenience of one-stop shopping.

Consumer health will post further growth over forecast period

Consumer healthcare in Italy will continue to perform well and post healthy growth over the forecast period. Manufacturers are expecting legislation to become clearer and so easier to be interpreted as this would definitely allow investment on new product developments. At the same time manufacturers are expected to benefit form the fact that Italians will increasingly focus on prevention over cure. This will boost spending across a number of fields including diet, sport and healthcare.


Samples (FAQs about samples):

doc_pdf.png Sample Consumer Health Market Research Report

doc_excel_table.png Sample Consumer Health Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Italy with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Italy, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Italy for free:

The Consumer Health in Italy market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Italy?
  • What are the major brands in Italy?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Table of Contents

Table of Contents

Consumer Health in Italy - Industry Overview

EXECUTIVE SUMMARY

Task-specific and new products led growth

Consumer health is increasingly fragmented

Health and Beauty Retailers keep the lion’s share

Consumer health will post further growth over forecast period

KEY TRENDS AND DEVELOPMENTS

Increasing awareness of prevention – health and beauty

Poor economy has a varied impact on OTC products and dietary supplements

Consumers still lack trust in generics, but private label develops slowly

Chemists/pharmacies is still the cornerstone of distribution

Increasing Interest in herbal/traditional products and organic ingredients

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  • Table 2 Life Expectancy at Birth 2006-2011

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2006-2011
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2006-2011
  • Table 5 Consumer Health Company Shares 2007-2011
  • Table 6 Consumer Health Brand Shares 2008-2011
  • Table 7 Penetration of Private Label by Category 2006-2011
  • Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  • Table 9 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
  • Table 10 Forecast Sales of Consumer Health by Category: Value 2011-2016
  • Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

APPENDIX

Non-prescription medicines: registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventative medicine impacting consumer health

Switches

  • Summary 1 OTC - Switches 2010-2011

DEFINITIONS

SOURCES

  • Summary 2 Research Sources

Consumer Health in Italy - Company Profiles

A Menarini Industrie Farmaceutiche Riunite Srl in Consumer Health (Italy)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 5 A Menarini Industrie Farmaceutiche Riunite Srl: Competitive Position 2011

Aziende Chimiche Riunite Angelini Francesco ACRAF SpA in Consumer Health (Italy)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 8 Aziende Chimiche Riunite Angelini Francesco ACRAF SpA: Production Statistics

COMPETITIVE POSITIONING

  • Summary 9 Aziende Chimiche Riunite Angelini Francesco ACRAF SpA: Competitive Position 2011

Bayer SpA in Consumer Health (Italy)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 12 Bayer SpA: Competitive Position 2011

Bracco SpA in Consumer Health (Italy)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 15 Bracco SpA: Competitive Position 2011

Chiesi Farmaceutici SpA in Consumer Health (Italy)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 18 Chiesi Farmaceutici SpA: Competitive Position 2011

Perfetti Van Melle SpA in Consumer Health (Italy)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 21 Perfetti Van Melle SpA: Competitive Position 2011

Recordati Industria Chimica e Farmaceutica SpA in Consumer Health (Italy)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 24 Recordati Industria Chimica e Farmaceutica SpA: Production Statistics

COMPETITIVE POSITIONING

  • Summary 25 Recordati Industria Chimica e Farmaceutica SpA: Competitive Position 2011

Sanofi-Aventis SpA in Consumer Health (Italy)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 28 Sanofi-Aventis SpA: Competitive Position 2011

Sigma-Tau Industrie Farmaceutiche Riunite SpA in Consumer Health (Italy)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 31 Sigma-Tau Industrie Farmaceutiche Riunite SpA: Competitive Position 2011

Zambon Italia SpA in Consumer Health (Italy)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 34 Zambon Italia SpA: Production Statistics

COMPETITIVE POSITIONING

  • Summary 35 Zambon Italia SpA: Competitive Position 2011

Adult Mouth Care in Italy - Category Analysis

HEADLINES

TRENDS

  • Adult mouth care recorded an increase of 2% in current value terms in 2011, with sales reaching €89 million. This category includes products for mouth ulcers, oral analgesics and non-prescription mouthwashes. Over the review period sales were mainly driven by the good performance of mouthwashes. In 2010 mouthwashes continued to perform well, despite the increased competition posed by cosmetic products which fall outside consumer health, such as Listerine and Colgate. The consumer base is mainly made up of elderly people, who use adult mouth care products to alleviate the pain and discomfort related to the use of dental products and dentures. The customer base is widening, however, to middle-aged people and children, as prevention in the early stages has proven to be effective in terms of avoiding problems later.

SWITCHES

COMPETITIVE LANDSCAPE

  • SIFRA Societá Italiana Farmaceutici Ravizza continued to lead adult mouth care in 2011, with a value share of 42%, up slightly from the previous year. The company led with its well-established Froben brand. It was followed by GlaxoSmithKline, with a share of 17% with its Goccemed brand, but it saw a decrease of one percentage point from 2010. Pfizer Consumer Healthcare was third with the Oraseptic brand, holding a value share of 12%.

PROSPECTS

  • Adult mouth care is expected to decrease slowly over the forecast period, with a negative constant value CAGR of 1%. Non-prescription mouthwashes will continue to benefit from significant advertising investment to support cosmetic mouthwashes, despite having to compete with such products, as advertising helps to increase consumer awareness of oral health. Other products, such as those to treat mouth ulcers, and oral analgesics, will see only modest advertising support. No other key operators are looking to extend their brands into adult mouth care.

CATEGORY DATA

  • Table 12 Sales of Adult Mouth Care: Value 2006-2011
  • Table 13 Sales of Adult Mouth Care: % Value Growth 2006-2011
  • Table 14 Adult Mouth Care Company Shares by Value 2007-2011
  • Table 15 Adult Mouth Care Brand Shares by Value 2008-2011
  • Table 16 Forecast Sales of Adult Mouth Care: Value 2011-2016
  • Table 17 Forecast Sales of Adult Mouth Care: % Value Growth 2011-2016

Analgesics in Italy - Category Analysis

HEADLINES

TRENDS

  • Sales of analgesics continued to decline in 2011. This was due to consumers switching to Rx products such as Oki, Aulin and Nimesulide. Despite warnings of the side-effects of Rx analgesics, Italians considered price convenience as the priority. 2011 instead saw the key products which determine OTC analgesics in Italy, that is Tachipirina (acetaminophen-based product) and Aspirina registering outstanding performances. This was mainly because of aggressive distribution and advertising strategies, which encouraged consumers to switch back to OTC products.

SWITCHES

COMPETITIVE LANDSCAPE

  • Aziende Chimiche Riunite Angelini Francesco ACRAF (Angelini) remained the leading company in analgesics in Italy in 2011, with a 36% share of value sales, increasing from 33% in 2010. Its leading position was due to the positive performance of systemic analgesics such as acetaminophen, a category led by Angelini through its Tachipirina brand. Moment, another popular brand from Angelini (a systemic analgesic), continued to benefit from the launch of Moment Act, a more powerful variant of the original, and at the end of 2010 from the launch of a new format of Moment – soft pills. Angelini, together with the other key players in ibuprofen, is benefiting from the main innovation, which is the double-dose; therefore with Moment 400mg consumers can have the best efficacy available with no need for a prescription.

PROSPECTS

  • Manufacturers are expected to focus on products with which consumers are familiar, therefore those based on acetaminophen and aspirin. Ibuprofen and ketoprofen will also continue to expand. Systemic analgesics is expected to see a steady CAGR of 1%, as in the review period.

CATEGORY DATA

  • Table 18 Sales of Analgesics by Category: Value 2006-2011
  • Table 19 Sales of Analgesics by Category: % Value Growth 2006-2011
  • Table 20 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2006-2011
  • Table 21 Analgesics Company Shares by Value 2007-2011
  • Table 22 Analgesics Brand Shares by Value 2008-2011
  • Table 23 Forecast Sales of Analgesics by Category: Value 2011-2016
  • Table 24 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016

Calming and Sleeping in Italy - Category Analysis

HEADLINES

TRENDS

  • Calming and sleeping recorded growth of 3% in current value terms in 2011, with sales reaching €20 million. The prevalence of sleep problems, particularly insomnia, is increasing, with Italians leading busier lifestyles and experiencing more stress, particularly with the recent economic downturn and future uncertainty.

SWITCHES

COMPETITIVE LANDSCAPE

  • In 2011, calming and sleeping continued to be led by Solvay Pharma, although the company continued to lose share, with a decrease of eight percentage points from 2008.

PROSPECTS

  • Over the forecast period calming and sleeping is predicted to post 2% growth in constant value terms. Increased levels of stress (potentially further exacerbated by economic concerns) and the growing number of older Italians are predicted to underpin the rising number of people with sleeping problems.

CATEGORY DATA

  • Table 25 Sales of Calming and Sleeping: Value 2006-2011
  • Table 26 Sales of Calming and Sleeping: % Value Growth 2006-2011
  • Table 27 Calming and Sleeping Company Shares by Value 2007-2011
  • Table 28 Calming and Sleeping Brand Shares by Value 2008-2011
  • Table 29 Forecast Sales of Calming and Sleeping: Value 2011-2016
  • Table 30 Forecast Sales of Calming and Sleeping: % Value Growth 2011-2016

Cough, Cold and Allergy (Hay Fever) Remedies in Italy - Category Analysis

HEADLINES

TRENDS

  • The influenza season in 2011 was worse than in 2010 and the preceding years, seeing the rate at least as double. Nevertheless, consumers continued to express concern regarding the adverse side-effects of allopathic products. As a result, Italians increasingly shifted towards natural remedies. In cases of coughs, colds, flu and pharyngeal irritations, Italian consumers are accustomed to deciding themselves what product to use, usually well-known syrups and/or tablets, often after taking advice from a chemist/pharmacist, rather than visiting a general practitioner for a prescribed drug.

SWITCHES

COMPETITIVE LANDSCAPE

  • Cough, cold and allergy (hay fever) remedies is not as fragmented as before, with the top six players accounting for a 47% share of value sales in 2011. Boehringer Ingelheim Italia overtook GlaxoSmithKline (13% value share in 2011) in 2010, registering a value share of 14% in 2011. Despite the launch of the nasal decongestant plaster Breathe Right in 2008, which helped to consolidate GlaxoSmithKline’s position, Boehringer Ingelheim Italia indisputably led high value categories such as combination products with the brand Zerinol and its variant of Zerinol Flu, and cough remedies with the top brands Bisolvon and Mucosolvan. It held an 18% value share in combination products, and a share of 36% in cough remedies in 2011. GlaxoSmithKline is more visible in nasal decongestants, and continues to operate with dynamism and innovation in communication and with aggressive distribution strategies.

PROSPECTS

  • Changing consumer attitudes to purchasing OTC products will be key to the performance of cough, cold and allergy remedies over the forecast period. Cough remedies will continue to be sold mainly through chemists/pharmacies, since consumers will often require advice from a chemist/pharmacist about their use (such as correct dosage, time of treatment, etc). However, decongestants and pharyngeal preparations are likely to increasingly be bought in grocery retailers. Consumers will find it more convenient and cheaper to purchase these products in supermarkets, due to their prices being 10-20% lower.

CATEGORY DATA

  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 32 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 33 Sales of Decongestants by Category: Value 2006-2011
  • Table 34 Sales of Decongestants by Category: % Value Growth 2006-2011
  • Table 35 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 36 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 37 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2007-2011
  • Table 38 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2008-2011
  • Table 39 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016
  • Table 40 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016

Digestive Remedies in Italy - Category Analysis

HEADLINES

TRENDS

  • 2011 saw an increased trend of maintaining a healthy digestive system amongst consumers, and consequently preventative products became more popular, with consumers leaning towards solving the causes of problems rather than opting only for symptom-relief products. In particular, on the one hand consumers were increasingly choosing herbal formulations, which are perceived as less prone to side-effects than synthetic digestive remedies, whilst on the other hand they were becoming significantly more aware of what was available in OTC digestive remedies. Therefore they often opted for specific remedies such as antacids and proton pump inhibitors, rather than just IBS treatments, for example. Furthermore, Italians were showing an increasing preference for preventive measures, such as increased intake of water and healthy food in their diets, together with less sedentary lifestyles, as well as greater interest in fibre and probiotic supplements.

SWITCHES

COMPETITIVE LANDSCAPE

  • McNeil maintained the leading position in digestive remedies throughout 2011, accounting for an 11% share of value sales. The company entered digestive remedies in Italy in 2008, following the acquisition of the Imodium brand from Centra Medicamenta OTC. The company’s leading position is due to the popularity of its brand Imodium, which is the leader in diarrhoeal remedies, and one of the few products available in this category. Imodium continues to be competitive, having developed since 2008 another two formats for administering the product, a fizzy format which also contains mineral supplements, and the latest, orosoluble, to be taken on any occasion when out and having no water available.

PROSPECTS

  • Over the forecast period retail sales of digestive remedies are projected to increase by a CAGR of 1% in constant value terms, to €419 million. The increasing proportion of elderly Italians, who usually suffer more from digestive problems, will contribute to future demand, together with the professional working class with stress-related problems. In addition, the fact that in 2011 there were still thousands of people who suffered from gastro-intestinal problems but did not cure themselves, led to high potential for the development of some categories, such as antacids and proton pump inhibitors. However, improving the daily diet, such as increasing the intake of fibre-rich food, is expected to negatively impact demand for some remedies, such as laxatives, IBS treatments and paediatric digestive remedies. Increased awareness of healthy eating is likely to continue to encourage consumers to conduct a balanced lifestyle, and the increased introduction of digestive care and maintenance products will help to minimise the need for regular digestive relief products in the coming years.

CATEGORY DATA

  • Table 41 Sales of Digestive Remedies by Category: Value 2006-2011
  • Table 42 Sales of Digestive Remedies by Category: % Value Growth 2006-2011
  • Table 43 Digestive Remedies Company Shares by Value 2007-2011
  • Table 44 Digestive Remedies Brand Shares by Value 2008-2011
  • Table 45 Forecast Sales of Digestive Remedies by Category: Value 2011-2016
  • Table 46 Forecast Sales of Digestive Remedies by Category: % Value Growth 2011-2016

Ear Care in Italy - Category Analysis

HEADLINES

TRENDS

  • Ear care remained fairly steady in 2011, recording an increase of 1% in current value terms, with sales of €21 million. There were no significant new product developments during the review period, although 2011 saw an interesting innovation, Debrox, which is an isotonic solution, comes with a specially shaped rubber syringe to help the user when applying the solution. In general, consumers are either increasingly shifting towards natural solutions to cure minor problems, or are opting for Rx medicines for anything more serious.

SWITCHES

COMPETITIVE LANDSCAPE

  • Ear care remained dominated by two main players in 2011, Laboratoire Vifor France and Zambon Italia. Laboratoire Vifor France led with a value share of 33%, thanks to the success of its Otalgan brand. Otalgan benefits from a long presence in the market, and from being a well-known product, despite a lack of advertising investment.

PROSPECTS

  • Over the forecast period retail sales of ear care products are expected to decrease only slightly, with a negative CAGR of 1% in constant value terms. No significant new product development is expected in ear care, with the exception of natural remedies. Consumers will continue to shift towards either natural products or Rx medicines, which are perceived as safer or more effective than non-prescription medicines.

CATEGORY DATA

  • Table 47 Sales of Ear Care: Value 2006-2011
  • Table 48 Sales of Ear Care: % Value Growth 2006-2011
  • Table 49 Ear Care Company Shares by Value 2007-2011
  • Table 50 Ear Care Brand Shares by Value 2008-2011
  • Table 51 Forecast Sales of Ear Care: Value 2011-2016
  • Table 52 Forecast Sales of Ear Care: % Value Growth 2011-2016

Eye Care in Italy - Category Analysis

HEADLINES

TRENDS

  • Eye care recorded an increase of 1% in current value terms in 2011, with sales increasing slightly to €106 million. Convenience is becoming a key consideration in the choice of products, with consumers preferring single-dose products over multi-dose formats. Single-dose products do not require the consumer to use the product within a certain timeframe, as with larger formats.

SWITCHES

COMPETITIVE LANDSCAPE

  • The competitive landscape in eye care is led by a few key operators, but is also characterised by the presence of a large number of manufacturers mainly producing artificial tears, and now ophthalmic drops.

PROSPECTS

  • OTC eye care faces strong competition from Rx products in the form of eye drops and creams. In addition to less serious pathologies, for which self-medication is preferred, the use of dietary supplements at systemic level is increasing, as research is producing ever more specific supplements which provide certain active ingredients which are better absorbed systemically than topically. Nevertheless, the industry will continue to invest in natural variants of both standard and allergy eye care products, also encouraging consumers to buy topical remedies, with the appeal of offering non-invasive solutions and no side-effects on such a delicate part of the body.

CATEGORY DATA

  • Table 53 Sales of Eye Care by Category: Value 2006-2011
  • Table 54 Sales of Eye Care by Category: % Value Growth 2006-2011
  • Table 55 Standard Eye Care by Format: % Value Breakdown 2007-2011
  • Table 56 Standard Eye Care by Positioning: % Value Breakdown 2007-2011
  • Table 57 Eye Care Company Shares by Value 2007-2011
  • Table 58 Eye Care Brand Shares by Value 2008-2011
  • Table 59 Forecast Sales of Eye Care by Category: Value 2011-2016
  • Table 60 Forecast Sales of Eye Care by Category: % Value Growth 2011-2016

Herbal/Traditional Products in Italy - Category Analysis

HEADLINES

TRENDS

  • In the last couple of years, clinical studies intensified to test the efficacy of herbal products in the treatment of certain pathologies, such as inflammatory diseases (arthritis and back pain, for example), hypertension and coughs and colds, and for the body as a whole. This resulted in better information and wider knowledge about herbal/traditional products and their benefits. In 2011, demand for herbal/traditional remedies continued to be supported by consumers’ increased knowledge about the effectiveness of such remedies, and of holistic therapies. Moreover, the category benefited from consumer concern over the negative side-effects associated with some prescription and non-prescription medications. The negative reporting of these products led consumers to seek out alternatives in herbal/traditional products, which are perceived as safer than prescription and non-prescription medications.

SWITCHES

COMPETITIVE LANDSCAPE

  • Herbal/traditional products is very fragmented, although the leading five players together accounted for almost 29% of overall value sales. Aboca, with an 11% value share, led herbal/traditional products, mainly driven by the dietary supplement Bio Valoe Detox, containing pure aloe juice from Venezuela. Aboca is very innovative in the natural fibre category, with Digerbe, and also with products for cholesterol and cardiovascular problems, such as Ruscoven Method, a combined product made of dietary supplement and biogel, which favours the functionality of the micro-circulation. Aboca offers many alternatives in combination dietary supplements, for example with supplements specific for the memory, for the menopause and for the menstrual cycle. To boost the immune system, Aboca offers Immunomix for children and adults. Another successful line is Natura Mix, distributed especially in juice format to increase energy and give balance to the body through vitamins, ginseng and other specific ingredients. The company is also present in weight management with the line Fitomagra, with the launch in 2011 of Adiprox, a dietary supplement to lose weight with the added effect of green tea and grape seeds.

PROSPECTS

  • One of the key factors driving the further development of herbal/traditional products will be the continuing appearance of clinical studies indicating the efficacy of these products. Research is likely to lean towards dispositivi medico, to treat symptoms through a mechanical effect rather than by introducing active principles into the system (as allopathic medicines do), with the aim of eliminating side-effects. Another factor boosting growth will be the decreasing competition from homeopathic products, which continue to be negatively impacted by unfavourable opinions from medical experts.

CATEGORY DATA

  • Table 61 Sales of Herbal/Traditional Products: Value 2006-2011
  • Table 62 Sales of Herbal/Traditional Products: % Value Growth 2006-2011
  • Table 63 Herbal/Traditional Products Company Shares 2007-2011
  • Table 64 Herbal/Traditional Products Brand Shares 2008-2011
  • Table 65 Forecast Sales of Herbal/Traditional Products: Value 2011-2016
  • Table 66 Forecast Sales of Herbal/Traditional Products: % Value Growth 2011-2016

Medicated Skin Care in Italy - Category Analysis

HEADLINES

TRENDS

  • 2011 strong growth rates in Medicated skin care clearly witnesses how Italians are becoming aware of the risk related to a bad care of their skin. Media’s campaigns aimed to increase people’s awareness towards the risk of sun unprotected exposure, sharing communal spaces, or using generic products for example, have been very effective.

SWITCHES

COMPETITIVE LANDSCAPE

  • Bayer remained the leader in medicated skin care in 2011, accounting for an 11% share of value sales. The company was able to maintain its leading position largely with its main umbrella brand, Canesten, which can also be administered to children, the variant Unidie, which has to be applied only once a day, and Gynocanesten. A significant contribution was also made by its secondary brands, such as Proctosedyl in haemorrhoid treatments, and also Bepanthol, which performed significantly above the category average in 2011, posting a 13% sales increase.

PROSPECTS

  • Medicated skin care is expected to decline over the forecast period, although with a gradual negative CAGR of 1% in constant value terms, as was also seen in the review period. Neither consumers nor retailers see medicated skin care as a unified category. As a result, the overall growth rate will be the result of the performance of a series of unrelated product types. In line with the trend in the review period, sales will benefit from Italian consumers’ growing interest in healthy skin, as part of overall good health. Proper skin care treatment is also widely regarded as essential in preventing premature skin ageing, which is an increasing concern amongst consumers in Italy, as Italians are now much more aware of the consequences of unresolved skin problems.

CATEGORY DATA

  • Table 67 Sales of Medicated Skin Care by Category: Value 2006-2011
  • Table 68 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  • Table 69 Medicated Skin Care Company Shares by Value 2007-2011
  • Table 70 Medicated Skin Care Brand Shares by Value 2008-2011
  • Table 71 Hair Loss Treatments Brand Shares by Value 2008-2011
  • Table 72 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  • Table 73 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016

NRT Smoking Cessation Aids in Italy - Category Analysis

HEADLINES

TRENDS

  • The majority of people who still smoke are well-aware of the health impact of smoking, but nonetheless choose to continue. The declining trend in NRT smoking cessation aids is leading to a lack of interest amongst manufacturers.

SWITCHES

COMPETITIVE LANDSCAPE

  • In 2011 only three main manufacturers were present in NRT smoking cessation aids: Carlo Erba OTC (Pfizer Group) with Nicorette; Novartis Consumer Health with Nicotinell; and GlaxoSmithKline with Niquitin CQ. Carlo Erba continued to dominate in 2011, its Nicorette brand held a 97% share of NRT gum, or a 64% share of overall NRT smoking cessation aids in 2011.

PROSPECTS

  • Lozenges is expected to see a positive trend in the forecast period as the new mini lozenges by GlaxoSmithKline are expected to register positive sales in the coming years. NRT gum will still be present and still be the leading category in terms of penetration, although it is expected to decline at about 6% annual rate.

CATEGORY INDICATORS

  • Table 74 Number of Smokers by Gender 2006-2011

CATEGORY DATA

  • Table 75 Sales of NRT Smoking Cessation Aids by Category: Value 2006-2011
  • Table 76 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2006-2011
  • Table 77 NRT Gum Flavours: % Value Breakdown 2006-2011
  • Table 78 NRT Smoking Cessation Aids Company Shares by Value 2007-2011
  • Table 79 NRT Smoking Cessation Aids Brand Shares by Value 2008-2011
  • Table 80 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2011-2016
  • Table 81 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2011-2016

Sports Nutrition in Italy - Category Analysis

HEADLINES

TRENDS

  • With longer working hours and rising obesity rates, Italians are increasingly expressing a willingness to increase their level of physical activity. Anecdotal evidence, as well as fitness industry sources, indicate that a rising number of people have fitness club membership. This trend is further supported by vanity and health concerns amongst younger Italians, especially young single professionals, who pay considerable attention to their physical appearance and body shape, and for whom gym sessions are the most suitable sports activity to fit with their busy lifestyles, offering the opportunity of exercise at almost any time of the day.

SWITCHES

COMPETITIVE LANDSCAPE

  • Despite US and German multinationals threat, the leading player in sports nutrition in 2011 was the domestic company, Enervit, followed by Proaction, Eurosup, Nutrition & Santé and Atlantic Grupa. The number of small distributors is more contained than in the past, although still widely present. Many of these companies do not remain in the market for long, but in the meantime they create strong price competition, mostly damaging the larger brands.

PROSPECTS

  • Demand for sports nutrition is expected to increase over the forecast period, as the desire to remain healthy and active, along with maintaining good nutrition, will increase in Italy. With a rising obesity rate and more sedentary lifestyles, sports nutrition companies are expected to benefit from assisting consumers with their overall quest for fitness. Unlike weight loss supplements, which usually control the metabolism or calorie/fat absorption, sports nutrition products can make a workout more productive and rewarding in the long term.

CATEGORY DATA

  • Table 82 Sales of Sports Nutrition: Value 2006-2011
  • Table 83 Sales of Sports Nutrition: % Value Growth 2006-2011
  • Table 84 Sports Nutrition Company Shares 2007-2011
  • Table 85 Sports Nutrition Brand Shares 2008-2011
  • Table 86 Forecast Sales of Sports Nutrition: Value 2011-2016
  • Table 87 Forecast Sales of Sports Nutrition: % Value Growth 2011-2016

Vitamins and Dietary Supplements in Italy - Category Analysis

HEADLINES

TRENDS

  • Vitamins and dietary supplements performed very well in 2011, posting health growth of 7%. However it is important to point out that different products experienced different trends. More specific products such as vitamin B and E and probiotic supplements performed far better than in the previous year. On the other hand much more well know and generic products such vitamin C and multivitamins among others declined. These two different trends show how Italians have become very careful about the products they buy and use. There is greater awareness of dietary needs and the benefits of various supplements taken individually or together.

VITAMINS

DIETARY SUPPLEMENTS

SWITCHES

COMPETITIVE LANDSCAPE

  • Whitehall Italia, Sanofi-Aventis and Bayer continued to be the three leading companies in vitamins and dietary supplements in 2011, as in 2010. Whitehall kept its leading position in 2011 due to the competitive strength of its two main brands, Polase and Centrum. Polase registered an outstanding performance due to the company its reducing prices, following Polase being reclassified as Notificato rather than OTC. Centrum is available in six different varieties, segmented by age and specific conditions, such as cardiovascular problems, or with the last variant, Materna, for women who are pregnant or breast-feeding.

PROSPECTS

  • Increased concern about health and wellbeing is expected to lead to rising consumption of vitamins and dietary supplements across every age range, including babies and children, over the forecast period. The category will also be impacted by the ageing of the Italian population, and by the increasing attention paid to the female consumer group. Manufacturers will increasingly target specific consumer groups within the middle-aged population, segmenting by sex and by functional problems. For example, glucosamine saw good growth at the end of the review period due to its positioning for joints – an area of particular importance to the older population – and manufacturers are now beginning to target the supplement towards people undertaking sporting activities, regardless of their age.

CATEGORY DATA

  • Table 88 Sales of Vitamins and Dietary Supplements by Category: Value 2006-2011
  • Table 89 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2006-2011
  • Table 90 Dietary Supplements by Positioning 2006-2011
  • Table 91 Vitamins and Dietary Supplements Company Shares by Value 2007-2011
  • Table 92 Vitamins and Dietary Supplements Brand Shares by Value 2008-2011
  • Table 93 Vitamins Brand Shares by Value 2008-2011
  • Table 94 Dietary Supplements Brand Shares by Value 2008-2011
  • Table 95 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2011-2016
  • Table 96 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2011-2016
  • Summary 36 Dietary Supplements: Brand Ranking by Positioning 2011

Weight Management in Italy - Category Analysis

HEADLINES

TRENDS

  • Weight management saw a positive performance in 2011, driven by consumers’ desire to lose weight in order to reach their goal of having an attractive, slim body, and also because the correct weight is increasingly associated with health and wellness in the long term. Moreover, consumer demand was supported by a wide offer of high-quality products, as manufacturers are required to meet the standards imposed by the relevant European law (Direttiva Europea 2002/46) for product quality and safety. Because of the increasing obesity rate amongst children, the Ministry is reinforcing the message that it is essential to start treating obesity as a concrete pathology which will have serious repercussions for health in the coming years, but also that is not just a health problem, but also a socioeconomic one. The Ministry is proposing that primary, secondary and high schools should have classes in the principles of nutrition, as well as ensuring that physical activity takes place within school hours.

SWITCHES

COMPETITIVE LANDSCAPE

  • Herbalife Italia led weight management in 2011, due to its leading position in meal replacement slimming, with an overall 37% value share, with a slight decline in share from 2010. This was not due to its unsuccessful performance, but to the fact that there are many more minor manufacturers which are now focusing on weight management products, both domestic and international. Herbalife’s dominant position is also in weight loss supplements, with a 51% value share. Herbalife heavily supports these products, as they are amongst its leading product lines. Its success is partly based on the fact that the company emphasises its worldwide, long-standing experience in high-quality slimming products. Formula 1 is still its core product, and at the end of 2011 it launched a limited edition of the product with a slightly different formulation specifically for the Christmas holidays in 2011, with no allergens, therefore no soya and no gluten.

PROSPECTS

  • The forecast period is predicted to see a slight slowdown in growth compared with the 5% CAGR observed in the review period, with a constant value CAGR of 3%. The market for weight management products has become more tightly regulated in terms of both Italian and European laws, which greatly limits the launch of new products. Products will be subject to rigid checks with regard to slimming claims, in order to protect consumers and provide them with adequate information about the products’ actual benefits. Moreover, this category will continue to shift towards the use of more natural ingredients. Mixes of herbal extracts widely known as fat reducers, such as pineapple stem, or natural detoxifying diuretic products, such as birch, dandelion, equisetum, artichoke, bardana or acai, will increasingly be used in the formulae of slimming products, and consequently consumers will be reassured about the non-toxicity of new products.

CATEGORY DATA

  • Table 97 Sales of Weight Management: Value 2006-2011
  • Table 98 Sales of Weight Management: % Value Growth 2006-2011
  • Table 99 Weight Management Company Shares 2007-2011
  • Table 100 Weight Management Brand Shares 2008-2011
  • Table 101 Forecast Sales of Weight Management: Value 2011-2016
  • Table 102 Forecast Sales of Weight Management: % Value Growth 2011-2016

Wound Care in Italy - Category Analysis

HEADLINES

TRENDS

  • Wound care recorded growth of 3% in current value terms in 2011, with sales reaching €169 million. Price competition remained the key strategy in maintaining value share for the major players, both within the more dynamic category of sticking plasters/adhesive bandages and also in gauze, tape and other wound care. Chemists/pharmacies saw a decrease in share, with sales being cannibalised by mass-market distribution channels.

SWITCHES

COMPETITIVE LANDSCAPE

  • Private label held a larger share than any individual manufacturer in wound care in 2011, overall accounting for a 27% share of value sales. However, in 2011 private label recorded a decrease due to the intense price competition applied by branded products. This is a category in which brand-loyalty is very low, since the quality of wound care products is considered more or less comparable across all types of standard products (plasters, gauze and liquid disinfectants). As a result, consumers are inclined to buy the cheapest products in more commoditised areas, such as plasters, particularly following the economic downturn. The brand is, however, considered important in the case of more innovative products, such as liquid and spray plasters.

PROSPECTS

  • Wound care is expected to see a negligible CAGR between 2011 and 2016, to reach €172 million in constant value terms, from €169 million in 2011. Price positioning is expected to continue to be important in wound care, with the major players looking to increase their shares. In order to compete effectively against private label, manufacturers are likely to continue to invest in the launch of new products, and this may well lead to a degree of polarisation in wound care.

CATEGORY DATA

  • Table 103 Sales of Wound Care by Category: Value 2006-2011
  • Table 104 Sales of Wound Care by Category: % Value Growth 2006-2011
  • Table 105 Wound Care Company Shares by Value 2007-2011
  • Table 106 Wound Care Brand Shares by Value 2008-2011
  • Table 107 Forecast Sales of Wound Care by Category: Value 2011-2016
  • Table 108 Forecast Sales of Wound Care by Category: % Value Growth 2011-2016

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Paediatric Cough, Cold and Allergy Remedies
          • Paediatric Allergy Remedies
          • Paediatric Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Paediatric Digestive Remedies
          • Paediatric Diarrhoeal Remedies
          • Paediatric Indigestion and Heartburn Remedies
          • Paediatric Laxatives
          • Paediatric Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Paediatric Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
      • Protein Products
        • Bars
        • Powder
        • RTD
        • Other Protein
      • Non-Protein Products
    • Vitamins and Dietary Supplements
      • Paediatric Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Aloe
            • Fibre
            • Other Other Herbal/Traditional Dietary Supplements
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
            • Lecithin
            • Propolis
            • Other Other Non-Herbal Dietary Supplements
      • Tonics and Bottled Nutritive Drinks
      • Vitamins
        • Multivitamins
        • Single Vitamins
          • Vitamin A
          • Vitamin B
          • Vitamin C
          • Vitamin D
          • Vitamin E
          • Other Single Vitamins
    • Weight Management
      • Meal Replacement Slimming
      • OTC Obesity
      • Slimming Teas
      • Weight Loss Supplements
      • Other Slimming Products
    • Herbal/Traditional Products
      • Herbal/Traditional Analgesics
      • Herbal/Traditional Calming and Sleeping Products
      • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
      • Herbal/Traditional Digestive Remedies
      • Herbal/Traditional Medicated Skin Care
      • Herbal/Traditional Medicinal Teas
      • Herbal/Traditional Smoking Cessation Aids
      • Herbal/Traditional Paediatric Dietary Supplements
      • Herbal/Traditional Dietary Supplements
      • Herbal/Traditional Tonics and Bottled Nutritive Drinks
    • Allergy Care
      • Allergy Eye Care
      • Antihistamines/Allergy Remedies (Systemic)
      • Paediatric Allergy Remedies
      • Topical Allergy Remedies/Antihistamines
    • Paediatric Consumer Health
      • Paediatric Analgesics
        • Paediatric Acetaminophen
        • Paediatric Aspirin
        • Paediatric Combination Products - Analgesics
        • Paediatric Diclofenac
        • Paediatric Dipyrone
        • Paediatric Ibuprofen
        • Paediatric Ketoprofen
        • Paediatric Naproxen
      • Paediatric Cough, Cold and Allergy Remedies
        • Paediatric Allergy Remedies
        • Paediatric Cough/Cold Remedies
      • Paediatric Digestive Remedies
        • Paediatric Diarrhoeal Remedies
        • Paediatric Indigestion and Heartburn Remedies
        • Paediatric Laxatives
        • Paediatric Motion Sickness Remedies
      • Paediatric Medicated Skin Care
      • Nappy (Diaper) Rash Treatments
      • Paediatric Vitamins and Dietary Supplements

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market sizes
  • Company shares
  • Brand shares
  • Distribution
  • Analysis by format
  • Analysis by positioning
  • Analysis by type
  • Herbal/traditional vs standard
  • Pricing
  • Smoking population - number of adult smokers
  • Smoking prevalence - % of adult population

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?

If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!